Inhibition of nitric oxide with aminoguanidine reduces bacterial translocation after endotoxin challenge in vivo. 1996

D L Sorrells, and C Friend, and U Koltuksuz, and A Courcoulas, and P Boyle, and M Garrett, and S Watkins, and M I Rowe, and H R Ford
Department of Surgery, University of Pittsburgh School of Medicine, Pa., USA.

BACKGROUND Administration of lipopolysaccharide (LPS) has been shown to increase bacterial translocation (BT) in vivo and in vitro. In addition, LPS upregulates inducible nitric oxide synthase expression in the intestinal epithelium-a phenomenon that can either enhance microbial killing, or alternatively, promote BT by impairing the gut barrier. OBJECTIVE To determine the effect, if any, of an inhibitor of nitric oxide synthase, namely, aminoguanidine (AG), on BT after LPS challenge. METHODS Sprague-Dawley rats were randomized to receive either AG or normal saline solution via subcutaneously placed osmotic pumps (Alzet), followed 18 hours later by LPS injection (5 mg/kg or 20 mg/kg intraperitoneally). Quantitative cultures of the cecum, mesenteric lymph nodes, liver, and spleen were obtained, and plasma nitrite and nitrate levels were measured at 24 hours. Transmembrane potential difference and mucosal permeability to fluorescein isothiocyanate-labeled dextran and fluorescein isothiocyanate-labeled Escherichia coli C25 were measured in the Using chamber. The intestinal membrane was examined by light, transmission electron, and confocal laser microscopy. RESULTS Rats that were given high-dose LPS had elevated levels of nitrite and nitrate and a 100% incidence of BT. In contrast, AG infusion significantly reduced both BT (22%) and nitrite and nitrate levels. Animals that received LPS and normal saline solution had a significantly lower transmembrane potential difference than those that received LPS and AG. High-dose LPS resulted in sloughing of the apical enterocytes at the villus tips where bacterial entry seemed to occur, as seen with confocal laser microscopy. CONCLUSIONS Inhibition of nitric oxide production with AG decreases BT after high-dose LPS challenge. The mechanism may involve increased cellular viability and decreased damage to the gut mucosal barrier in rats that receive AG.

UI MeSH Term Description Entries
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008297 Male Males
D008564 Membrane Potentials The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization). Resting Potentials,Transmembrane Potentials,Delta Psi,Resting Membrane Potential,Transmembrane Electrical Potential Difference,Transmembrane Potential Difference,Difference, Transmembrane Potential,Differences, Transmembrane Potential,Membrane Potential,Membrane Potential, Resting,Membrane Potentials, Resting,Potential Difference, Transmembrane,Potential Differences, Transmembrane,Potential, Membrane,Potential, Resting,Potential, Transmembrane,Potentials, Membrane,Potentials, Resting,Potentials, Transmembrane,Resting Membrane Potentials,Resting Potential,Transmembrane Potential,Transmembrane Potential Differences
D008643 Mesentery A layer of the peritoneum which attaches the abdominal viscera to the ABDOMINAL WALL and conveys their blood vessels and nerves. Mesenteries
D009566 Nitrates Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical. Nitrate
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D009573 Nitrites Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M Nitrite

Related Publications

D L Sorrells, and C Friend, and U Koltuksuz, and A Courcoulas, and P Boyle, and M Garrett, and S Watkins, and M I Rowe, and H R Ford
December 1999, The American journal of physiology,
D L Sorrells, and C Friend, and U Koltuksuz, and A Courcoulas, and P Boyle, and M Garrett, and S Watkins, and M I Rowe, and H R Ford
January 1998, The Journal of trauma,
D L Sorrells, and C Friend, and U Koltuksuz, and A Courcoulas, and P Boyle, and M Garrett, and S Watkins, and M I Rowe, and H R Ford
August 2001, Shock (Augusta, Ga.),
D L Sorrells, and C Friend, and U Koltuksuz, and A Courcoulas, and P Boyle, and M Garrett, and S Watkins, and M I Rowe, and H R Ford
July 2001, American journal of physiology. Gastrointestinal and liver physiology,
D L Sorrells, and C Friend, and U Koltuksuz, and A Courcoulas, and P Boyle, and M Garrett, and S Watkins, and M I Rowe, and H R Ford
August 1998, The British journal of surgery,
D L Sorrells, and C Friend, and U Koltuksuz, and A Courcoulas, and P Boyle, and M Garrett, and S Watkins, and M I Rowe, and H R Ford
November 1997, Archives of surgery (Chicago, Ill. : 1960),
D L Sorrells, and C Friend, and U Koltuksuz, and A Courcoulas, and P Boyle, and M Garrett, and S Watkins, and M I Rowe, and H R Ford
January 1999, Transplantation proceedings,
D L Sorrells, and C Friend, and U Koltuksuz, and A Courcoulas, and P Boyle, and M Garrett, and S Watkins, and M I Rowe, and H R Ford
October 2001, Pancreas,
D L Sorrells, and C Friend, and U Koltuksuz, and A Courcoulas, and P Boyle, and M Garrett, and S Watkins, and M I Rowe, and H R Ford
November 2004, American journal of physiology. Endocrinology and metabolism,
D L Sorrells, and C Friend, and U Koltuksuz, and A Courcoulas, and P Boyle, and M Garrett, and S Watkins, and M I Rowe, and H R Ford
January 1996, Methods in enzymology,
Copied contents to your clipboard!